MedPath

University Eye Associates, PC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein

Phase 4
Suspended
Conditions
Fluorescein Angiography
Interventions
First Posted Date
2017-08-10
Last Posted Date
2020-03-16
Lead Sponsor
Kresge Eye Institute
Target Recruit Count
79
Registration Number
NCT03244982
Locations
🇺🇸

Kresge Eye Institute, Detroit, Michigan, United States

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Not Applicable
Withdrawn
Conditions
Sickle Cell Anemia
Retinopathy
Interventions
First Posted Date
2008-02-20
Last Posted Date
2012-09-27
Lead Sponsor
Kresge Eye Institute
Registration Number
NCT00618644
Locations
🇺🇸

Kresge Eye Institute, Detroit, Michigan, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.